Meanwhile, the Trump administration has issued termination notices to thousands of federal health department workers, including those at the FDA responsible for reviewing AI products. This move could slow the development and evaluation of AI in healthcare, potentially hindering safety frameworks and adoption. In other news, XRHealth is acquiring RealizedCare to strengthen its position in therapeutic VR, and Prenuvo has raised $120 million for its full-body imaging technology, amid debates on the value of preventative health screenings.
Key takeaways:
- Abridge announced a $250 million Series D fundraise, highlighting its focus on streamlining clinical documentation and financial workflows using AI technology.
- Thousands of workers at the federal health department, including those reviewing AI products at the FDA, received termination notices, potentially impacting AI development and safety evaluations.
- XRHealth is pursuing a provider-based model for VR-based treatments, acquiring RealizedCare to enhance its platform for therapeutic virtual reality.
- Prenuvo raised $120 million for full-body imaging technology, with FDA clearance for its Body Composition software, amid debates on the value of preventative health screening.